Mankind Pharma has announced that its board of directors will convene on September 24, 2024, to discuss and potentially approve a proposal to raise funds through the issuance of various securities. The company is considering multiple options, including non-convertible debentures, commercial papers, and other forms of debt securities, according to a regulatory filing.
Read MoreSubscribe to our newsletter to get updates on our latest news